Prospective study of the efficacy of pancreatic enzyme replacement therapy for non-alcoholic fatty liver disease after pancreatectomy
Phase 3
- Conditions
- Pancreatic or biliary tract disease required pancreatectomy
- Registration Number
- JPRN-UMIN000008556
- Lead Sponsor
- Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with acute ischemic heart disease 2.Patients with preoperative fatty liver/liver cirrhosis, viral hepatitis or alcoholic liver disease 3.Patients with heavy use of alcohol 4.Patients with interstitial pneumonia or fibroid lung who require oxygen administration 5.Patients with chronic renal failure requiring dialysis 6.Patients with other malignant disease 7.Patients who have a hypersensitivity to Lipacreon® or pig protein 8.Patients who are diagnosed to be ineligible by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method